What Should Rocket Lab Stock Holders Take From Its Third Quarter

For questions about this article or underlying research, email [email protected].

Rocket Lab (RKLB) stock rose 6.5% on November 10, 2026, the session following its Q3 FY2026 report. Sales exceeded management's own forecast, but the larger shift occurred in the work customers signed for future delivery. That matters for a stock priced at 46.4 times its last twelve months of sales, compared with 3.2 times for the S&P 500. How large was that change, set against what Rocket Lab sells today?

Rocket Lab's Backlog Rose More Than A Year's Sales

Rocket Lab added about $1.2 billion to its backlog in Q3 FY2026 alone, a figure exceeding the $882 million of revenue it reported over the last twelve months. This influx brought the total backlog to $3.57 billion. Launches account for roughly half of that backlog, and customers signed 54 of them with Rocket Lab during the quarter.

Beyond the backlog, the stock's move stood apart as well. On the same session the S&P 500 slipped 0.4%, while three of Rocket Lab's larger peers, Lockheed Martin, Northrop Grumman and L3Harris, rose between 1.7% and 2.5%.

When Does Rocket Lab's Backlog Turn Into Revenue?

Management expects 32.9% of the backlog to become revenue within the next 12 months, representing roughly $1.17 billion of sales from work already signed. Sales are already growing, with revenue reaching $268 million in Q3 FY2026, up 14.4% from Q2.

For Q4 FY2026, management forecast revenue of $270 million to $290 million, which it put at 4.5% growth over Q3 at the midpoint. Management said solar and satellite platforms, two parts of its Space Systems business, are expected to decline after a very strong Q3, while the rest of Space Systems should rise. So Rocket Lab has sales from signed work lined up for the next 12 months, and it guided Q4 FY2026 to slower growth than Q3 delivered.

Neutron Delay Is A Risk For Rocket Lab Holders

Some of the new work involves Neutron, a larger rocket that has yet to fly. Rocket Lab signed eight Neutron launches for roughly $515 million in Q3, and management said Neutron's first 16 launches are now booked. The company moved Neutron's first launch to 2027 after voids were found in a propellant tank. On the November 9 call, management declined to give a date, offering frequent updates on the tank instead.

Rocket Lab also recorded a reserve in Q3 against a possible loss on Neutron's second flight. Management said the reserve reflects Neutron's early stage and the possible hit to that flight's profit. Rocket Lab's operating loss was $79.2 million in Q3 FY2026, against $59.0 million a year earlier, and management expects Neutron spending to stay elevated through the first launch. Management said adjusted EBITDA, its own profit measure, will turn positive within six months of Neutron's first successful flight, with cash flow following later. So holders are waiting on a launch date that management has not set.

The quarter's main change for Rocket Lab holders came in signed work rather than in sales. The backlog at the end of Q4 FY2026, due with results expected in February 2027, is the figure to watch.

Want A Second Look At What You Own?

Rocket Lab is one decision in a portfolio. Whether you work with an advisor or manage your money yourself, a second look at the whole portfolio costs nothing. Our partner advisory firm offers a free written review of your holdings, fees and income plan, with no need to switch.

Get A Free Second Opinion

Spot an error or want more like this? Tell us in 10 seconds.